A unique epitope exposed in native complement component C9 and hidden in the terminal SC5b-9 complex enables selective detection and quantification of non-activated C9

This publication has 19 references indexed in Scilit:

• Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
  Journal of Clinical Investigation, 1985
• Monoclonal antibodies against neoantigens of the terminal C5b-9 complex of human complement
  Bioscience Reports, 1985
• Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme‐Linked Immunosorbent Assay Based on Monoclonal Antibodies against a Neoantigen of the Complex
  Scandinavian Journal of Immunology, 1985
• Monoclonal Antibodies Recognizing a Neoantigen of Poly(C9) Detect the Human Terminal Complement Complex in Tissue and Plasma
  Scandinavian Journal of Immunology, 1985
• Quantification of the C3d Split Products of Human Complement by a Sensitive Enzyme Linked Immunosorbent Assay
  Scandinavian Journal of Immunology, 1985
• Complement activation in Type 1 human diabetes
  Clinical Immunology and Immunopathology, 1985
• TERMINAL COMPONENT OF COMPLEMENT (C9) IN CEREBROSPINAL FLUID OF PATIENTS WITH MULTIPLE SCLEROSIS
  The Lancet, 1984
• Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
  Journal of Clinical Investigation, 1983
• Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly
  The Journal of Experimental Medicine, 1982
• Immunochemical analyses of membrane-bound complement: Detection of the terminal complement complex and its similarity to “intrinsic” erythrocyte membrane proteins
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1975